News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Nerium Biotechnology Applies To Cease Being A Reporting Issuer



2/26/2014 12:34:53 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN ANTONIO, TEXAS--(Marketwired - Feb. 25, 2014) - Nerium Biotechnology, Inc. ("the Company") wishes to announce that it has made application to the Ontario Securities Commission (the "Commission"), seeking a ruling pursuant to subsection 1(10)(a)(ii) of the Securities Act (Ontario) (the "Act") that it is not a reporting issuer. The Applicant is a reporting issuer only in Ontario and is not, and has never been, listed for trading on any stock exchange or quotation system, nor does it currently have any intention to do so. The Applicant has less than fifteen (15) beneficial security holders in the province of Ontario, and all have consented, in writing to the Company ceasing to be a reporting issuer in Ontario. Virtually all of the Company's operations are located in the United States and Central America, as are the vast majority of its shareholders.

Help employers find you! Check out all the jobs and post your resume.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES